Literature DB >> 11524020

Flexibility and bioactivity of insulin: an NMR investigation of the solution structure and folding of an unusually flexible human insulin mutant with increased biological activity.

D Keller1, R Clausen, K Josefsen, J J Led.   

Abstract

The structure and folding of a novel human insulin mutant, [Thr(B27) --> Pro, Pro(B28) --> Thr]insulin (PT insulin), in aqueous solution and in mixtures of water and 2,2,2-trifluoroethanol (TFE) have been studied by NMR spectroscopy. It was found that PT insulin has a highly flexible structure in pure water and is present in at least two different conformations, although with an overall tertiary structure similar to that of native insulin. Furthermore, the native helical structures are poorly defined. Surprisingly, the mutant has a biological activity about 50% higher than native insulin. In contrast, in TFE/water solution the mutant reveals a propensity of forming a well-defined structure at the secondary structure level, similar to monomeric native insulin. Thus, as shown by a detailed determination of the structure from 208 distance restraints and 52 torsion angle restraints by distance geometry, simulated annealing, and restrained energy minimization, the native insulin helices (A2-A7, A13-A19, and B10-B19) as well as the beta-turn (B20-B23) are formed in 35% TFE. However, the amount of tertiary structure is decreased significantly in TFE/water solution. The obtained results suggest that only an overall tertiary fold, as observed for PT insulin in pure water, is necessary for expressing the biological activity of insulin, as long as the molecule is flexible and retains the propensity to form the secondary structure required for its receptor binding. In contrast, a compact secondary structure, as found for native insulin in solution, is unnecessary for the biological activity. A model for the receptor binding of insulin is suggested that relates the increased bioactivity to the enhanced flexibility of the mutant.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11524020     DOI: 10.1021/bi0108150

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Non-equivalent role of inter- and intramolecular hydrogen bonds in the insulin dimer interface.

Authors:  Emília Antolíková; Lenka Žáková; Johan P Turkenburg; Christopher J Watson; Ivona Hančlová; Miloslav Šanda; Alan Cooper; Tomáš Kraus; A Marek Brzozowski; Jiří Jiráček
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

2.  Evidence of oligomerization of bovine insulin in solution given by NMR.

Authors:  S V Efimov; Yu O Zgadzay; N B Tarasova; V V Klochkov
Journal:  Eur Biophys J       Date:  2018-06-01       Impact factor: 1.733

3.  Structure-based stabilization of insulin as a therapeutic protein assembly via enhanced aromatic-aromatic interactions.

Authors:  Nischay K Rege; Nalinda P Wickramasinghe; Alisar N Tustan; Nelson F B Phillips; Vivien C Yee; Faramarz Ismail-Beigi; Michael A Weiss
Journal:  J Biol Chem       Date:  2018-06-07       Impact factor: 5.157

4.  Identifying signatures of proteolytic stability and monomeric propensity in O-glycosylated insulin using molecular simulation.

Authors:  Wei-Tse Hsu; Dominique A Ramirez; Tarek Sammakia; Zhongping Tan; Michael R Shirts
Journal:  J Comput Aided Mol Des       Date:  2022-05-04       Impact factor: 4.179

5.  Evaluating the intrinsic cysteine redox-dependent states of the A-chain of human insulin using NMR spectroscopy, quantum chemical calculations, and mass spectrometry.

Authors:  Alok K Sharma; Yan Ling; Allison B Greer; David A Hafler; Sally C Kent; Yong Zhang; Alan C Rigby
Journal:  J Phys Chem B       Date:  2010-01-14       Impact factor: 2.991

6.  Chemometric Methods to Quantify 1D and 2D NMR Spectral Differences Among Similar Protein Therapeutics.

Authors:  Kang Chen; Junyong Park; Feng Li; Sharadrao M Patil; David A Keire
Journal:  AAPS PharmSciTech       Date:  2017-11-06       Impact factor: 3.246

7.  Solution structure of a conformationally restricted fully active derivative of the human relaxin-like factor.

Authors:  Erika E Büllesbach; Mathias A S Hass; Malene R Jensen; D Flemming Hansen; Søren M Kristensen; Christian Schwabe; Jens J Led
Journal:  Biochemistry       Date:  2008-12-16       Impact factor: 3.162

8.  Insulin Dissociates by Diverse Mechanisms of Coupled Unfolding and Unbinding.

Authors:  Adam Antoszewski; Chi-Jui Feng; Bodhi P Vani; Erik H Thiede; Lu Hong; Jonathan Weare; Andrei Tokmakoff; Aaron R Dinner
Journal:  J Phys Chem B       Date:  2020-06-25       Impact factor: 2.991

9.  Structure of human insulin monomer in water/acetonitrile solution.

Authors:  Wojciech Bocian; Jerzy Sitkowski; Elzbieta Bednarek; Anna Tarnowska; Robert Kawecki; Lech Kozerski
Journal:  J Biomol NMR       Date:  2007-11-27       Impact factor: 2.835

10.  Computational IR Spectroscopy of Insulin Dimer Structure and Conformational Heterogeneity.

Authors:  Chi-Jui Feng; Anton Sinitskiy; Vijay Pande; Andrei Tokmakoff
Journal:  J Phys Chem B       Date:  2021-04-30       Impact factor: 2.991

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.